TDP-43 in the spectrum of MND-FTLD pathologies

Lanier Heyburn1, Charbel E-H Moussa2

  • 1Department of Neurology, Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Georgetown University Medical Center, Washington D.C. 20007, USA; Department of Pathology, Georgetown University Medical Center, Washington D.C., USA 20007.

Insights

Investigating TAR DNA binding protein 43 (TDP-43) in neurodegeneration reveals its role in protein imbalance and synaptic dysfunction. Understanding TDP-43

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • TAR DNA binding protein 43 (TDP-43) is an RNA-binding protein implicated in neurodegenerative diseases.
  • Perturbations in TDP-43 function can disrupt cellular homeostasis, leading to widespread downstream effects.
  • Understanding these disruptions is crucial for developing therapeutic interventions.

Purpose of the Study:

  • To review the current literature on TDP-43 and its associated pathologies.
  • To explore the consequences of TDP-43 overexpression and its impact on synaptic function.
  • To highlight existing knowledge gaps regarding TDP-43's contribution to disease.

Main Methods:

  • Literature review of existing studies on TDP-43.
  • Analysis of research on TDP-43 pathologies and overexpression.
  • Examination of studies detailing TDP-43's role in messenger RNA binding and synaptic protein disruption.

Main Results:

  • TDP-43 plays a critical role in numerous cellular processes.
  • Overexpression or dysfunction of TDP-43 can lead to significant cellular imbalances.
  • TDP-43 binding to messenger RNA contributes to the disruption of synaptic proteins and subsequent synaptic dysfunction.

Conclusions:

  • TDP-43 dysfunction is a key factor in neurodegeneration.
  • Further research is needed to fully elucidate TDP-43's complex role in disease pathogenesis.
  • Targeting TDP-43 pathways may offer therapeutic strategies for neurodegenerative conditions.

Related Concept Videos